Document is current
Any future updates will be listed below
-
Authors
Grymonprez, Maxim http://orcid.org/0000-0002-0145-6486
Capiau, Andreas
Steurbaut, Stephane
Boussery, Koen
Mehuys, Els
Somers, Annemie
Petrovic, Mirko
De Backer, Tine L.
Lahousse, Lies http://orcid.org/0000-0002-3494-4363
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (11C0820N)
- License Information
-
More Information
Article History
Accepted: 23 October 2023
First Online: 6 November 2023
Declarations
:
: This study was approved by the IMA and MHD database administrators and by the ‘Sectoral Committee of Social Security and Health, Section Health’, a subcommittee of the Belgian Commission for the Protection of Privacy (approval code IVC/KSZG/20/344), waiving the need for individual informed consents [CitationRef removed].
: Not applicable.
: Not applicable.
: Outside this manuscript, TDB has served as a chairperson during a lecture for Bayer and Daiichi Sankyo and participated in an expert meeting for Pfizer. Outside this manuscript, LL has been consulted as expert for AstraZeneca. Outside this manuscript, MP and SS have given a lecture sponsored by BMS, LL a lecture sponsored by Chiesi, and SS, LL and MG lectures sponsored by IPSA vzw, a non-profit organization facilitating lifelong learning for pharmacists. No author has received any fees personally.
